?

Van Naarden Jacob

EVP & Pres., Lilly Oncology
Eli Lilly and Company
US, Indianapolis [HQ]
CIK 1661254

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
15,463
Price per Share :
$725.72
Equivalence :
$11,221,808.36

Transaction History

  • M
    Form 4
    15,463 Shares After Transaction
    Value : $n/a
    $0.0
    02/01/24
  • Footnotes:
    No footnote found.
  • F
    Form 4
    13,778 Shares After Transaction
    Value : $8,895,214.58
    $1,087,852.85
    02/01/24
  • A
    Form 4
    16,147 Shares After Transaction
    Value : $11,904,537.22
    $1,746,568.94
    02/12/24
  • G
    Form 4
    11,845 Shares After Transaction
    Value : $n/a
    $0.0
    10/31/24